MedTrace Logo

Effectiveness and Implementation of eScreening in Post 9/11 Transition Programs

NCT04506164 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-02-17

Study results available
· View outcomes & findings →

Summary

Electronic screening is effective for timely detection of, and intervention for, suicidal ideation and other mental health symptoms. The VA eScreening program is a patient self-report electronic screening system that has shown promise for the efficient and effective collection of mental and physical health information among Veterans. However, additional effectiveness and implementation research is warranted to evaluate the impact of eScreening within VHA. This study addresses questions of the impact of eScreening compared to screening as usual, while evaluating a multi-component implementation strategy (MCIS) for optimal enterprise rollout of eScreening in VA Transition Care Management clinics.

Conditions

  • Depression
  • Stress Disorders, Post-Traumatic
  • Suicide

Interventions

OTHER

eScreening

eScreening is a clinical patient self report system that allows Veterans to complete self report screens, including assessments of depression, PTSD and alcohol use, using a secure connection from any internet connected device.

OTHER

Screening As Usual

Assessment of depression, PTSD and alcohol use using verbal and paper-based screening methods.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • James Pittman, PhD MSW · VA San Diego Healthcare System, San Diego, CA

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-18
Primary Completion
2023-12-29
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04506164 on ClinicalTrials.gov